/NNOX
NNOX Stock - Nano-X Imaging Ltd.
Healthcare|Medical - DevicesNASDAQ
$2.99+0.34%
+$0.01 (+0.34%) • Dec 19
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.2
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.78
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+502.0%upside
Target: $18.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NNOX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.96 – $3.02
TARGET (TP)$18.00
STOP LOSS$2.75
RISK/REWARD1:62.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.06
52W High$11.00
52W Low$2.78
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $11.28M | $9.90M | $8.58M | $1.30M | N/A |
| Gross Profit | $-10,609,000 | $-6,592,000 | $-6,880,000 | $-1,512,000 | $-208,000 |
| Gross Margin | -94.0% | -66.6% | -80.2% | -116.0% | N/A |
| Operating Income | $-56,746,000 | $-62,589,000 | $-109,710,000 | $-61,558,000 | $-43,923,000 |
| Net Income | $-53,516,000 | $-60,776,000 | $-105,243,000 | $-61,798,000 | $-43,499,000 |
| Net Margin | -474.3% | -613.6% | -1226.9% | -4739.1% | N/A |
| EPS | $-0.91 | $-1.08 | $-2.01 | $-1.28 | $-1.22 |
Company Overview
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
2
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
2 Bullish0 Neutral/Bearish
Price Targets
$20
Average Target
↑ 552.2% Upside
Now
$15
Low
$20
Average
$23
High
Based on 3 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| January 6th 2025 | D. Boral Capital | Initiation | Buy | $23 |
| September 8th 2023 | Alliance Global Partners | Initiation | Buy | $14.5 |
| January 5th 2023 | Cantor Fitzgerald | Initiation | Overweight | $21 |
Earnings History & Surprises
NNOXBeat Rate
28%
Last 18 quarters
Avg Surprise
-30.4%
EPS vs Estimate
Beats / Misses
5/13
Last 12 quarters
Latest EPS
$-0.65
Q4 2025
EPS Surprise History
Q1 24
+40.0%
$-0.18vs$-0.30
Q2 24
+30.8%
$-0.18vs$-0.26
Q3 24
-4.5%
$-0.23vs$-0.22
Q4 24
-4.5%
$-0.23vs$-0.22
Q2 25
No data
Q2 25
-10.5%
$-0.21vs$-0.19
Q3 25
-31.4%
$-0.23vs$-0.17
Q4 25
-333.3%
$-0.65vs$-0.15
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | — | — | — | — |
Q4 2025 | Nov 20, 2025 | $-0.15 | $-0.65 | -333.3% | ✗ MISS |
Q3 2025 | Aug 12, 2025 | $-0.17 | $-0.23 | -31.4% | ✗ MISS |
Q2 2025 | May 22, 2025 | $-0.19 | $-0.21 | -10.5% | ✗ MISS |
Q2 2025 | Apr 7, 2025 | — | $-0.18 | — | — |
Q4 2024 | Nov 21, 2024 | $-0.22 | $-0.23 | -4.5% | ✗ MISS |
Q3 2024 | Aug 20, 2024 | $-0.22 | $-0.23 | -4.5% | ✗ MISS |
Q2 2024 | Apr 1, 2024 | $-0.26 | $-0.18 | +30.8% | ✓ BEAT |
Q1 2024 | Mar 14, 2024 | $-0.30 | $-0.18 | +40.0% | ✓ BEAT |
Q4 2023 | Nov 28, 2023 | $-0.30 | $-0.37 | -23.3% | ✗ MISS |
Q3 2023 | Aug 17, 2023 | $-0.26 | $-0.31 | -19.2% | ✗ MISS |
Q2 2023 | May 22, 2023 | $-0.34 | $-0.21 | +38.2% | ✓ BEAT |
Q1 2023 | Mar 9, 2023 | $-0.57 | $-0.86 | -50.9% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $-0.45 | $-0.37 | +17.8% | ✓ BEAT |
Q3 2022 | Aug 16, 2022 | $-0.23 | $-0.38 | -65.2% | ✗ MISS |
Q2 2022 | May 19, 2022 | $-0.22 | $-0.41 | -86.4% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $-0.37 | $-0.44 | -18.9% | ✗ MISS |
Q4 2021 | Nov 17, 2021 | $-0.29 | $-0.28 | +3.4% | ✓ BEAT |
Q3 2021 | Aug 10, 2021 | $-0.24 | $-0.28 | -16.7% | ✗ MISS |
Q2 2021 | May 11, 2021 | $-0.24 | $-0.27 | -12.5% | ✗ MISS |
Latest News
NANO-X IMAGING Partners With Althea France To Distribute CE-Marked Nanox.ARC Imaging System Across French Healthcare Sector
📈 PositiveBenzinga•Nov 25, 2025, 01:13 PM
D. Boral Capital Maintains Buy on Nano X Imaging, Maintains $8 Price Target
📈 PositiveBenzinga•Nov 24, 2025, 03:44 PM
NANO-X IMAGING's Nanox.AI Subsidiary Secures Recommendation Of National Institute for Health and Care Excellence For Early Value Assessment In UK National Health Service hospitals
📈 PositiveBenzinga•Nov 24, 2025, 01:11 PM
D. Boral Capital Maintains Buy on Nano X Imaging, Maintains $8 Price Target
📈 PositiveBenzinga•Nov 20, 2025, 06:05 PM
Nano-X jumps as 2026 outlook beats consensus
📈 PositiveSeeking Alpha•Nov 20, 2025, 03:22 PM
NANO-X IMAGING shares are trading higher after the company reported better-than-expected Q3 EPS results and issued FY26 sales guidance above estimates.
📈 PositiveBenzinga•Nov 20, 2025, 02:21 PM
Nanox To Acquire VasoHealthcare IT From Vaso For Total Consideration Of Up To $800K
➖ NeutralBenzinga•Nov 19, 2025, 01:36 PM
D. Boral Capital Maintains Buy on Nano X Imaging, Maintains $8 Price Target
📈 PositiveBenzinga•Nov 18, 2025, 07:34 PM
Nano-X Imaging rises on partnership with 3DR Labs
📈 PositiveSeeking Alpha•Nov 18, 2025, 06:12 PM
Nano-X Imaging shares are trading higher after the company announced that it has signed a reseller collaboration with 3DR Labs to integrate its Nanox.AI's HealthCCSng, HealthOST, and HealthFLD into its imaging services portfolio.
📈 PositiveBenzinga•Nov 18, 2025, 03:14 PM
NANO-X Announces Strategic Reseller Partnership With 3DR Labs To Integrate Nanox.AI's HealthCCSng, HealthOST, And HealthFLD Into Imaging Services Portfolio
📈 PositiveBenzinga•Nov 18, 2025, 01:06 PM
NANO-X IMAGING Partners With Olympe Imagerie To Deploy Nanox.ARC In France
📈 PositiveBenzinga•Nov 14, 2025, 01:04 PM
NANO-X To Showcase Its Nanox.ARC X Multi-Source Digital Tomosynthesis System And Highlight Developments In Its AI Portfolio At The RSNA 2025 Annual Meeting In Chicago From November 30 To December 4, 2025
📈 PositiveBenzinga•Nov 13, 2025, 01:18 PM
Nanox Enters Distribution Agreement With EXRAY To Bring Nanox's Advanced Imaging Solutions To Healthcare Providers Throughout The Czech Republic
📈 PositiveBenzinga•Nov 6, 2025, 01:32 PM
Nano-X Imaging Enters Collaboration Between Its U.S. Subsidiary, Nanox Impact And Monarch Medical Management And Billing To Deploy Nanox's Advanced Imaging Solutions Across Various Healthcare Sectors
📈 PositiveBenzinga•Sep 18, 2025, 12:20 PM
Frequently Asked Questions about NNOX
What is NNOX's current stock price?
Nano-X Imaging Ltd. (NNOX) is currently trading at $2.99 per share. The stock has moved +0.34% today.
What is the analyst price target for NNOX?
The average analyst price target for NNOX is $18.00, based on 1 analyst.
What sector is Nano-X Imaging Ltd. in?
Nano-X Imaging Ltd. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is NNOX's market cap?
Nano-X Imaging Ltd. has a market capitalization of $0.19 billion, making it a small-cap company.
Does NNOX pay dividends?
No, Nano-X Imaging Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCATX
Perspective Therapeutics, Inc.
$2.75
Mkt Cap: $0.2B
HCAT
Health Catalyst, Inc.
$2.35
Mkt Cap: $0.2B
HSDT
Solana Company
$2.98
Mkt Cap: $0.1B
INGN
Inogen, Inc.
$6.71
Mkt Cap: $0.2B
MXCT
MaxCyte, Inc.
$1.50
Mkt Cap: $0.2B
OM
Outset Medical, Inc.
$3.70
Mkt Cap: $0.1B
PROF
Profound Medical Corp.
$7.63
Mkt Cap: $0.2B
QTRX
Quanterix Corporation
$6.59
Mkt Cap: $0.3B
SNWV
SANUWAVE Health, Inc.
$32.25
Mkt Cap: $0.3B
TLSI
TriSalus Life Sciences, Inc.
$7.42
Mkt Cap: $0.2B
Explore stocks similar to NNOX for comparison